FDA says some chemicals cause neuropsychiatric changes
Recalls and Warnings Influenza Drug Labels Get Warnings for Neuropsychiatric Changes Patients with influenza should be closely monitored for signs of abnormal behavior during treatment with Tamiflu and possibly also Relenza. (US Food and Drug Administration.)
Medscape Medical News
http://www.medscape.com/viewarticle/570996?sssdmh=dm1.339468&src=nldne
